Funded Startups in Maynard
Across the 5 most recent Maynard rounds shown, the only clearly outsized disclosed check is Boston Micro Fabrication’s $22M Series D on 2023-06-13; the oth…
Across the 5 most recent Maynard rounds shown, the only clearly outsized disclosed check is Boston Micro Fabrication’s $22M Series D on 2023-06-13; the other disclosed amounts cluster between $4M and $6M (AquaBounty Technologies at $5M on 2026-04-08, ClearGov at $4M on 2024-03-12, Telemynd at $6M on 2022-12-15), making the $22M entry stand out from the rest. Sector-wise, biotech appears twice (AquaBounty Technologies on 2026-04-08 and Latham BioPharm Group on 2023-06-21, undisclosed), while the remaining entries cover data/analytics (ClearGov), hardware (Boston Micro Fabrication), and health care (Telemynd).
The disclosed rounds also concentrate into two time bands rather than spreading evenly: two entries fall in mid-June 2023 (Latham BioPharm Group on 2023-06-21 and Boston Micro Fabrication on 2023-06-13), while the remaining disclosed amounts sit on 2022-12-15, 2024-03-12, and 2026-04-08. In staging, “Series Unknown” is common: 3 of 5 rows show an unknown series classification (AquaBounty Technologies, ClearGov, Telemynd), and one row is explicitly “Series D” (Boston Micro Fabrication) while one biotech entry is “undisclosed” in amount (Latham BioPharm Group).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Maynard among the most recent entries, and how does it compare to the others?
Boston Micro Fabrication’s $22M Series D on 2023-06-13 is the standout; the remaining disclosed amounts are $4M (ClearGov, 2024-03-12), $5M (AquaBounty Technologies, 2026-04-08), and $6M (Telemynd, 2022-12-15), with Latham BioPharm Group listed as “undisclosed” (2023-06-21).
Do these Maynard rounds cluster within specific dates, or are they evenly distributed?
They cluster in two windows: mid-June 2023 accounts for two entries (Boston Micro Fabrication on 2023-06-13 at $22M and Latham BioPharm Group on 2023-06-21 with an undisclosed amount). The other rounds land separately on 2022-12-15 ($6M), 2024-03-12 ($4M), and 2026-04-08 ($5M).
Are any sectors over-represented in this Maynard snapshot?
Biotechnology appears in 2 of the 5 rows (AquaBounty Technologies, 2026-04-08 at $5M; Latham BioPharm Group, 2023-06-21 with undisclosed amount). The other sectors are each represented once: data and analytics (ClearGov, 2024-03-12 at $4M), hardware (Boston Micro Fabrication, 2023-06-13 at $22M), and health care (Telemynd, 2022-12-15 at $6M).
What’s the stage mix—does a single series classification dominate?
“Series Unknown” shows up in 3 of 5 rows (AquaBounty Technologies on 2026-04-08 at $5M, ClearGov on 2024-03-12 at $4M, Telemynd on 2022-12-15 at $6M). Only one row is explicitly “Series D” (Boston Micro Fabrication on 2023-06-13 at $22M), and one biotech row has an undisclosed amount (Latham BioPharm Group on 2023-06-21).
Which entries are most recent, and which one is the oldest among the shown rounds?
The most recent round date shown is 2026-04-08 for AquaBounty Technologies at $5M. The oldest date shown is 2022-12-15 for Telemynd at $6M, leaving 2023-06-13 and 2023-06-21 as the two closest mid-year points.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.